Delta, Kelowna, BC - October 16, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of Cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 483 - Review of two years as we approach the anniversary of legalization in Canada
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today's podcast is sponsored by Cannabis Suisse Corp. ( OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
In today's podcast we take a quick look at the last two years of legalization as we approach the anniversary of legalization in Canada.
Year 1 - Obstacles and Accomplishments:
Legalization in Canada came about "to keep cannabis out of the hands of youth, to keep profits out of the pockets of criminals, and to protect public Health and safety by allowing adults access to legal cannabis."
Over these past two years we have seen the many obstacles placed on the cannabis industry by un-informed regulators, slow license processing as well as difficulties maintaining quality and consistency at scale.
In the first year, Cannabis 1.0, two of the largest factors impeding the industry's success in Canada were the lack of retail infrastructure as well as the many issues with quality and supply from producers.
While provinces like Alberta, Saskatchewan and Manitoba helped streamline retail licensing and build out their cannabis infrastructure by not limiting their license numbers, Canada's more populous provinces of BC, Ontario and Quebec were slow to grant licenses and had heavy restrictions and costs for start ups which discouraged growth in the first year.
This in turn kept the illicit market running strong especially in BC and Ontario where delivery options weren't available and purchases needed to be made directly through the government website or stores. The limited amount of retail infrastructure and government control of the retail sector also affected pricing which in turn also helped to boost illicit sales.
This inconsistency in retail development also caused issues with supply chains between provinces with some provinces running out of the product in short order and being stuck with empty shelves while others were stuck with unwanted stock that degraded to an unsellable quality.
The governing body of Health Canada was also heavily overwhelmed in its first year which left the medical side of the industry mostly abandoned for the recreational market as well as causing delays in products hitting shelves. These delays again led to product degradation and in the first year most products hitting shelves were poorly received by consumers who consistently commented on the dryness of the product, lack of terpenes, poor value perception and many issues with packaging.
While these obstacles may have slowed the progress of the industry, many producers were able to overcome these challenges and learned to adapt by concentrating more on their pre-rolls and larger format dry flower, we saw prices come down to more reasonable standards, and we started to see the premium flower category open up.
Year 2 - Cannabis 2.0 VS COVID:
The last year began with a heavy focus on the potential of Cannabis 2.0 products which had strong momentum, which was quickly slowed by COVID-19.
Now while the COVID pandemic certainly had negative impacts on the cannabis sector such as large scale layoffs, development stalls and supply chain issues we also saw some massive benefits come from this same pandemic.
One of the largest impacts to this industry over the last year is assuredly the fact that in many states and throughout Canada, cannabis businesses were deemed "essential businesses" and were allowed to continue operations so long as they followed proper safety protocols. This change from a fringe industry years before to essential during a pandemic has been the most impactful to the removal of the stigma surrounding cannabis and has helped change the perception of many from "drug" to "medicine".
Two other great benefits that came from COVID were the mass adoption of new technology platforms and retail forms as well as a great opportunity for R & D. With new restrictions put in place regarding social distancing and contactless payment, many of the technology platforms and online developments that were being slowly adopted in small phases took a massive boost and went from novelty to essential. Few retail stores had curbside pickup, delivery, online sales, online customer service or touchless payment options in store in year one, yet now at the end of this year this is a must have for your business to survive.
In the first year due to supply and demand issues product development and research took a back seat to bulk production whereas in year two we've seen a much heavier focus on quality and premium products, new formats and formulations and much more realistic understanding of consumer demands and preferences. While beverages have still been somewhat slow with regards to bringing products to market the overall Cannabis 2.0 market has grown expansively over this last year.
One other great improvement in the Canadian market this last year was the full implementation of the Medical Cannabis by Shoppers Program which finally helped better serve the medical community in Canada and has become a great template for medical programs globally.
Year 3 - What's Next:
From possible federal regulatory changes in the US to global expansion of the cannabis supply chain to potential record cannabis retails sales globally, the next year in Cannabis has a lot of speculation and excitement surrounding it.
Many key dominos fell into place in the international community this year with new import and export licences granted, more markets opening up to medicinal or recreational cannabis and again because of COVID, international shipping and supply chains are nore more adaptive and fluid than they've ever been before.
In Canada and the US many are expecting another year of record setting sales, especially now that there are far more product skus and formats available, the retail and supply chain infrastructure is much more streamlined and built out and access to cannabis has never been simpler with delivery, curbside pickup and contactless payments all available.
While it is well known that this has been an industry that's been negatively impacted many times by over speculation there is more optimism going into this October 17th then the two previous by all available metrics. It's going to be a good year for green.
Once again, today's podcast is sponsored by Cannabis Suisse Corp. ( OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/ .
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
Disclosure: Cannabis Suisse Corp. ( OTC: CSUI ),is a paid featured company on Investorideas.com
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android